Rocket Doctor AI’s Blueprint for Scaling Modern Healthcare

VANCOUVER, BC – September 09, 2026 – An upcoming company town hall is rarely a fulcrum for industry-wide attention. Yet, when Rocket Doctor AI Inc. convenes its stakeholders on September 14, the discussion will extend far beyond typical quarterly updates. The virtual event, co-led by the firm’s top executives, Dr. Essam Hamza and Dr. William Cherniak, is poised to articulate a strategy that is already reshaping the intersection of artificial intelligence and healthcare delivery. Following a second quarter marked by explosive growth in the U.S. market, the company is signaling a period of aggressive, focused expansion, built upon a foundation of physician-led technology and a mission to democratize access to care.

A Quarter of Strategic Execution

While many tech firms report growth, Rocket Doctor AI’s recently released Q2 2026 financials tell a story of deliberate and successful execution. The company posted quarterly revenue of $734,028, a formidable 43% year-over-year increase. More tellingly, its U.S. operations are hitting a significant inflection point. The number of completed patient visits in the United States surged by 196% in Q2 compared to the previous quarter, a clear indicator that its market entry strategy is gaining powerful traction.

Beneath the headline numbers lies a more nuanced narrative of strategic investment. The company's gross margin stood at 65%, a calculated decrease from 89% in the same quarter last year. Far from being a red flag, this shift reflects a fundamental change in the company’s revenue mix. As it scales its digital healthcare platform in the U.S., a larger portion of its costs now includes direct payments to the physicians providing care. This is the price of building a robust, clinician-centric network, a necessary investment to capture a commanding share of the American telehealth market, particularly within the complex Medicaid and Medicare ecosystems. This strategic spending is what fuels the triple-digit growth in patient encounters and lays the groundwork for long-term profitability.

The Clinical Engine: A Different Kind of AI

At the core of Rocket Doctor AI's value proposition is its proprietary technology, specifically the Global Library of Medicine (GLM). In an era saturated with the hype of generative AI, the GLM stands apart. It is not a "black box" language model but a deterministic, physician-built clinical intelligence engine. Developed with input from hundreds of physicians worldwide and refined through over 25,000 hours of expert curation, the system provides real-time, evidence-based decision support.

Its deterministic nature, built on a Bayesian decision engine, ensures that its clinical reasoning is mathematically sound, consistent, and—most importantly—fully auditable. Unlike generative AIs that can "hallucinate" information, the GLM’s outputs are tethered to verified medical evidence, providing clinicians with the rationale behind its suggestions rather than attempting to replace their judgment. This commitment to safety and explainability has earned significant external validation, including a competitive $2 million Phase 2 grant from the U.S. National Institutes of Health (NIH). This federal endorsement underscores the clinical rigor of the platform. Further cementing its position as an enterprise-grade solution, the company recently achieved SOC 2 Type 1 compliance, a critical milestone that validates its stringent security and operational controls.

Bridging the Gap: From Rural Canada to U.S. Medicaid

The company’s sophisticated AI is not an academic exercise; it is a tool deployed to solve one of healthcare’s most persistent challenges: access. Rocket Doctor AI has an explicit mission to serve underserved, rural, and remote communities, a strategy it is executing with precision in both Canada and the United States.

In the U.S., the firm is pursuing a multi-state expansion, with established operations in California, Maryland, and New York, and future growth targeted for Florida and Texas. The key to this strategy lies in securing in-network contracts with major insurance payers. This painstaking work has already extended its total in-network reach to over 24 million covered lives. The focus is squarely on populations that need it most. One California contract alone provides access for 450,000 Medicaid patients. In New York, a partnership with EngageWell has been extended through 2029 to provide virtual care to underserved adults, creating a sustainable model that combines grant funding with a pathway to Medicaid reimbursement.

This focus is mirrored in its Canadian operations, where the company continues to expand its pharmacy-based virtual care program to 50 independent pharmacies, with services covered by provincial insurance. By embedding its technology within communities and aligning its business model with public and private payers, Rocket Doctor AI is building a scalable infrastructure for equitable care.

Building a Competitive Moat in Digital Health

In the fast-moving digital health sector, a strong technology platform is only part of the equation. Rocket Doctor AI’s true competitive advantage—its "moat," as described in investor materials—is the painstakingly constructed ecosystem surrounding its technology. This includes the complex web of payer contracts, the multi-state clinician credentialing processes, and the specialized revenue cycle operations tailored for Medicaid and Medicare. This integrated infrastructure, built over nearly four years, represents a significant barrier to entry, giving the company what it estimates to be an 18-to-24-month lead over potential competitors.

This strategic depth is a direct result of its physician-led leadership. The combined expertise of Dr. Hamza and Dr. Cherniak ensures that the company's growth is grounded in clinical reality and operational pragmatism. As the company prepares to detail its vision for the remainder of 2026, it does so from a position of strength, armed with proven technology, accelerating market traction, and a clear-eyed strategy for redefining modern healthcare into a system that is not only more efficient but profoundly more equitable.